These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 2697398)
1. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). De Witte T; Zwaan F; Hermans J; Vernant J; Kolb H; Vossen J; Lönnqvist B; Beelen D; Ferrant A; Gmür J Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():38-9. PubMed ID: 2697398 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). De Witte T; Zwaan F; Hermans J; Vernant J; Kolb H; Vossen J; Lönnqvist B; Beelen D; Ferrant A; Gmür J Br J Haematol; 1990 Feb; 74(2):151-5. PubMed ID: 2180469 [TBL] [Abstract][Full Text] [Related]
3. Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 years. De Witte T; Muus P; De Pauw B; Haanen C Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():33-5. PubMed ID: 2697396 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648 [TBL] [Abstract][Full Text] [Related]
5. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia. de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713 [No Abstract] [Full Text] [Related]
6. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group. Arnold R; de Witte T; van Biezen A; Hermans J; Jacobsen N; Runde V; Gratwohl A; Apperley JF Bone Marrow Transplant; 1998 Jun; 21(12):1213-6. PubMed ID: 9674854 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692 [TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR; Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337 [TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165 [TBL] [Abstract][Full Text] [Related]
12. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Löffler H; Schmitz N; Gassmann W Hematol Oncol Clin North Am; 1992 Jun; 6(3):619-31. PubMed ID: 1613010 [TBL] [Abstract][Full Text] [Related]
13. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study. Ringdén O; Labopin M; Gluckman E; Hows JM; Bradley BA; Kolb HJ; Fouillard L; Jacobsen N; Vernant JP; Witz F; Harousseau JL; Gorin NC Bone Marrow Transplant; 1997 May; 19(10):963-8. PubMed ID: 9169639 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON). Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916 [TBL] [Abstract][Full Text] [Related]
15. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission]. Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123 [TBL] [Abstract][Full Text] [Related]
16. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184 [TBL] [Abstract][Full Text] [Related]
17. [Allogeneic bone marrow transplantation for two patients with acute myeloid leukemia with trilineage myelodysplasia (T-MDS)]. Fukushima T; Kuriyama K; Yoshida S; Nagai K; Miyazaki Y; Moriuti Y; Tomonaga M Rinsho Ketsueki; 1994 Feb; 35(2):171-6. PubMed ID: 8139116 [TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Hasle H; Kerndrup G; Yssing M; Clausen N; Ostergaard E; Jacobsen N; Jacobsen BB Leukemia; 1996 Aug; 10(8):1269-73. PubMed ID: 8709630 [TBL] [Abstract][Full Text] [Related]
19. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [TBL] [Abstract][Full Text] [Related]
20. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Békássy AN; Hermans J; Gorin NC; Gratwohl A Bone Marrow Transplant; 1996 May; 17(5):801-8. PubMed ID: 8733701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]